Status:
COMPLETED
Neurotrophin Expression in Infants as a Predictor of Respiratory and Neurodevelopmental Outcomes
Lead Sponsor:
The Cleveland Clinic
Conditions:
Bronchopulmonary Dysplasia
Chronic Lung Disease
Eligibility:
All Genders
1-4 years
Brief Summary
Important developmental processes continue until the completion of 40 weeks gestation. Even during fetal life, intrinsic and environmental factors determine the balance between health and the onset an...
Detailed Description
Currently, there is no reliable method to identify infants who will have poor neurodevelopmental and respiratory outcomes. The ability to make such predictions would be beneficial for both making care...
Eligibility Criteria
Inclusion
- intubated infants in the Neonatal Intensive Care Unit (NICU)
Exclusion
- unwilling or unable to give or obtain informed consent
Key Trial Info
Start Date :
December 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2019
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03373539
Start Date
December 1 2014
End Date
August 1 2019
Last Update
November 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cleveland Clinic
Cleveland, Ohio, United States, 44195